We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

171 hedge funds and large institutions have $717M invested in Regenxbio in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

18% more capital invested

Capital invested by funds: $610M → $717M (+$107M)

8% more funds holding

Funds holding: 159 → 171 (+12)

6.54% more ownership

Funds ownership: 84.26% → 90.8% (+6.5%)

14% less call options, than puts

Call options by funds: $1.74M | Put options by funds: $2.02M

23% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 61

Holders
171
Holders Change
+12
Holders Change %
+7.55%
% of All Funds
2.49%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
32
Increased
47
Reduced
61
Closed
20
Calls
$1.74M
Puts
$2.02M
Net Calls
-$279K
Net Calls Change
-$2.69M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$57.4M
2
RG
Redmile Group
California
+$20.9M
3
PA
Perceptive Advisors
New York
+$6.03M
4
IHAM
Integral Health Asset Management
New York
+$5.72M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$10.4M
2
First Manhattan
First Manhattan
New York
-$10.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$8.97M
4
ECM
ExodusPoint Capital Management
New York
-$8.17M
5
Goldman Sachs
Goldman Sachs
New York
-$4.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$3.52M -$10.4M -591,550 -75%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.83M +$1.99M +113,012 +253%
Macquarie Group
28
Macquarie Group
Australia
$2.67M – – –
UBS Group
29
UBS Group
Switzerland
$2.66M +$1.43M +81,231 +121%
Invesco
30
Invesco
Georgia
$2.62M -$1.53M -87,027 -37%
Bank of America
31
Bank of America
North Carolina
$2.38M -$456K -25,867 -16%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$2.17M -$194K -11,020 -8%
Two Sigma Investments
33
Two Sigma Investments
New York
$2.07M +$1.49M +84,859 +281%
Barclays
34
Barclays
United Kingdom
$2.01M +$532K +30,197 +37%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$2M +$82.7K +4,697 +4%
Legal & General Group
36
Legal & General Group
United Kingdom
$1.98M +$2.18K +124 +0.1%
Assenagon Asset Management
37
Assenagon Asset Management
Luxembourg
$1.91M +$1.88M +106,682 New
N
38
Nuveen
North Carolina
$1.9M +$63.3K +3,591 +4%
Mirae Asset Global Investments
39
Mirae Asset Global Investments
South Korea
$1.69M -$2.01M -113,889 -55%
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
$1.62M -$440K -25,000 -22%
Public Sector Pension Investment Board (PSP Investments)
41
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.51M +$599K +34,006 +68%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.4M -$141K -8,000 -9%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$1.38M +$652K +37,000 +98%
HWAM
44
Hennion & Walsh Asset Management
New Jersey
$1.32M +$235K +13,336 +22%
Citigroup
45
Citigroup
New York
$1.3M -$517K -29,375 -29%
TI
46
Trexquant Investment
Connecticut
$1.26M -$278K -15,799 -18%
Stifel Financial
47
Stifel Financial
Missouri
$1.22M +$37.8K +2,148 +3%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$1.22M +$759K +43,070 +174%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.19M +$292K +16,593 +33%
RJFSA
50
Raymond James Financial Services Advisors
Florida
$1.18M -$864K -49,059 -43%
1
2
3 4 5

RGNX Hedge Fund Activity: Q4 2023 in Review

171 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2023, worth a combined $717M — up 18% from $610M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new RGNX positions and 20 closed out — a net gain of 12 holders — while 47 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $57.4M. The largest seller was Balyasny Asset Management, cutting an estimated $10.4M.

  • 171 institutional investors held Regenxbio (RGNX) as of Q4 2023, up from 159 in Q3 2023.
  • Funds reported $717M of Regenxbio stock for Q4 2023, up 18% quarter-over-quarter.
  • 32 funds opened new Regenxbio positions in Q4 2023 and 20 closed out, a net change of +12 holders.
  • The largest Regenxbio buyer in Q4 2023 was Morgan Stanley, an estimated $57.4M added.
  • The largest Regenxbio seller in Q4 2023 was Balyasny Asset Management, an estimated $10.4M sold.

Based on aggregated 13F filings for Q4 2023.